Rocca B, Spain L M, Puré E, Langenbach R, Patrono C, FitzGerald G A
Center for Experimental Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
J Clin Invest. 1999 May 15;103(10):1469-77. doi: 10.1172/JCI6400.
Prostaglandin G and H synthases, or cyclooxygenases (COXs), catalyze the formation of prostaglandins (PGs). Whereas COX-1 is diffusely expressed in lymphoid cells in embryonic day 15.5 thymus, COX-2 expression is sparse, apparently limited to stromal cells. By contrast, COX-2 is predominant in a subset of medullary stromal cells in three- to five-week-old mice. The isozymes also differ in their contributions to lymphocyte development. Thus, experiments with selective COX-1 inhibitors in thymic lobes from normal and recombinase-activating gene-1 knockout mice support a role for this isoform in the transition from CD4(-)CD8(-) double-negative (DN) to CD4(+)CD8(+) double-positive (DP). Concordant data were obtained in COX-1 knockouts. Pharmacological inhibition and genetic deletion of COX-2, by contrast, support its role during early thymocyte proliferation and differentiation and, later, during maturation of the CD4 helper T-cell lineage. PGE2, but not other PGs, can rescue the effects of inhibition of either isoform, although it acts through distinct EP receptor subtypes. COX-dependent PG generation may represent a mechanism of thymic stromal support for T-cell development.
前列腺素G和H合酶,即环氧化酶(COXs),催化前列腺素(PGs)的形成。在胚胎第15.5天的胸腺中,COX-1在淋巴细胞中广泛表达,而COX-2的表达较少,显然仅限于基质细胞。相比之下,在3至5周龄小鼠的一部分髓质基质细胞中,COX-2占主导地位。这两种同工酶对淋巴细胞发育的作用也有所不同。因此,在来自正常小鼠和重组酶激活基因-1敲除小鼠的胸腺叶中使用选择性COX-1抑制剂进行的实验支持了这种同工型在从CD4(-)CD8(-)双阴性(DN)向CD4(+)CD8(+)双阳性(DP)转变中的作用。在COX-1基因敲除小鼠中也获得了一致的数据。相比之下,COX-2的药理学抑制和基因缺失支持了其在早期胸腺细胞增殖和分化过程中以及随后在CD4辅助性T细胞谱系成熟过程中的作用。PGE2而非其他PGs可以挽救抑制任何一种同工型的效果,尽管它通过不同的EP受体亚型发挥作用。COX依赖性PG的产生可能代表了胸腺基质支持T细胞发育的一种机制。